“Cipla historically has always been a big respiratory and acute player but not that big in the diabetes area,” said Umang Vohra, managing director and global CEO of Cipla in an interview to ET.

Cipla vows to crack diabetes segment with licensed branded portfolio

Sharekhan recommended Hold rating on Cipla with a target price of Rs 1030 in its research report dated May 23, 2023.

Hold Cipla; target of Rs 1030: Sharekhan

KR Choksey is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1167 in its research report dated May 17, 2023.

Buy Cipla; target of Rs 1167: KR Choksey

Cipla had inked a perpetual license agreement with Novartis, as part of its strategy to grow the One India franchise towards a higher share of chronic therapies. Galvus and its combination brands had clocked sales of ₹270 crore, upto March 2023, and would strengthen the company’s diabetes portfolio.

Cipla builds on its diabetes portfolio with Galvus agreement

Benchmark indices start flat today as HDFC Bank and HDFC drag at open, while Cipla and Divi's Lab gain. PSU Bank, Realty, Pharma and IT indices are in green, while Pvt Bank drags. Asian markets are trading on a mixed note.

#marketopeningbell #stockmarketupdates #sensex #nifty #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday   

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. 
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Subscribe to our Channel: https://bit.ly/3nvEcxf

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

Benchmark Indices Open Flat, Nifty Above 18,400, Sensex Down 31 Points | Bazaar Open Exchange

Broker’s call: Cipla (Add)

Cipla stock slipped 3.98% to Rs 897.7 against the previous close of Rs 934.90 on BSE. The large cap share has lost 1.38 % in one year and fallen 13.34% since the beginning of this year.

Cipla shares fall 4% post Q4 earnings; what should investors do?

Hero MotoCorp, Tata Motors, ITC, Tech Mahindra and HUL were among the top gainers on the Nifty, while losers were Adani Enterprises, Cipla, BPCL, Divis Labs and Grasim Industries.

Taking Stock: Market at 5-month high with Nifty around 18,400; Sensex gains 318 points

Indian benchmark indices ended on a positive note today with Nifty around 18,400.

Hero MotoCorp, Tata Motors, ITC, Tech Mahindra and HUL were among the top gainers on the Nifty, while losers were Adani Enterprises, Cipla, BPCL, Divis Labs and Grasim Industries.

Except power, all other sectoral indices ended in the green with realty index up nearly 5 percent, FMCG index up 1 percent, while bank, auto, capital goods, information technology and metal up 0.5 percent each.

BSE midcap and smallcap indices rose 0.5 percent each.

 #marketclosingbell #sensex #nifty #stockmarketupdates #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday  

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. 
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Subscribe to our Channel: https://bit.ly/3nvEcxf

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

Indices End Near Day’s High, Nifty Ends Around 18,400, Sensex Gains 280 Points | NSE Closing Bell

Indian indices opened flat today amid weak global cues.

The Sensex was up 43.76 points or 0.07% at 62,071.66, and the Nifty was up 15.50 points or 0.08% at 18,330.30. About 1276 shares advanced, 821 shares declined, and 164 shares unchanged.

Tata Motors, Bajaj Auto, Power Grid Corporation, Hero MotoCorp and Britannia Industries were among major gainers on the Nifty, while losers were Cipla, Adani Enterprises, Divis Labs, Sun Pharma and Tata Consumer Products.


#marketopeningbell #sensex #nifty #stockmarketupdates #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday   

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. 
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Subscribe to our Channel: https://bit.ly/3nvEcxf

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

Indices Open Flat Amid Weak Global Cues, Sensex Up 43 Points, Nifty Around 18,330 | CNBC-TV18

Cipla Q4: Motilal Oswal expect 12.3% earnings CAGR over FY23-25, led by 9%/11% sales CAGR in DF/NA segments and marginal improvement in profitability.

Cipla reports 45% jump in Q4 net profit; what should investors do now?

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.

Cipla Ltd